001     134078
005     20210129211606.0
024 7 _ |a WOS:000308721100013
|2 WOS
024 7 _ |a 0033-8230
|2 ISSN
024 7 _ |a 2193-3405
|2 ISSN
024 7 _ |a 10.1524/ract.2012.1966
|2 doi
024 7 _ |a 2128/16375
|2 Handle
037 _ _ |a FZJ-2013-02438
041 _ _ |a English
082 _ _ |a 540
100 1 _ |a Qaim, Syed M.
|0 P:(DE-Juel1)131840
|b 0
|e Corresponding author
|u fzj
245 _ _ |a The present and future of medical radionuclide production
260 _ _ |a München
|c 2012
|b Oldenbourg
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1515392551_28980
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Medical radionuclide production technology is well established. Both reactors and cyclotrons are utilized for production; the positron emitters, however, are produced exclusively using cyclotrons. A brief survey of the production methods of most commonly used diagnostic and therapeutic radionuclides is given. The emerging radionuclides are considered in more detail. They comprise novel positron emitters and therapeutic radionuclides emitting low-range electrons and a-particles. The possible alternative production routes of a few established radionuclides, like Ga-68 and Tc-99m, are discussed. The status of standardisation of production data of the commonly used as well as of some emerging radionuclides is briefly mentioned. Some notions on anticipated future trends in the production and application of radionuclides are considered.
536 _ _ |a 333 - Pathophysiological Mechanisms of Neurological and Psychiatric Diseases (POF2-333)
|0 G:(DE-HGF)POF2-333
|c POF2-333
|f POF II
|x 0
536 _ _ |a 89573 - Neuroimaging (POF2-89573)
|0 G:(DE-HGF)POF2-89573
|c POF2-89573
|f POF II T
|x 1
588 _ _ |a Dataset connected to Web of Science, , juser.fz-juelich.de
650 _ 7 |2 WoSType
773 _ _ |a 10.1524/ract.2012.1966
|0 PERI:(DE-600)2039575-9
|n 8-9
|p 635 - 651
|t Radiochimica acta
|v 100
|y 2012
856 4 _ |u https://juser.fz-juelich.de/record/134078/files/%5BRadiochimica%20Acta%5D%20The%20present%20and%20future%20of%20medical%20radionuclide%20production.pdf
|y OpenAccess
856 4 _ |u https://juser.fz-juelich.de/record/134078/files/%5BRadiochimica%20Acta%5D%20The%20present%20and%20future%20of%20medical%20radionuclide%20production.gif?subformat=icon
|x icon
|y OpenAccess
856 4 _ |u https://juser.fz-juelich.de/record/134078/files/%5BRadiochimica%20Acta%5D%20The%20present%20and%20future%20of%20medical%20radionuclide%20production.jpg?subformat=icon-1440
|x icon-1440
|y OpenAccess
856 4 _ |u https://juser.fz-juelich.de/record/134078/files/%5BRadiochimica%20Acta%5D%20The%20present%20and%20future%20of%20medical%20radionuclide%20production.jpg?subformat=icon-180
|x icon-180
|y OpenAccess
856 4 _ |u https://juser.fz-juelich.de/record/134078/files/%5BRadiochimica%20Acta%5D%20The%20present%20and%20future%20of%20medical%20radionuclide%20production.jpg?subformat=icon-640
|x icon-640
|y OpenAccess
909 C O |o oai:juser.fz-juelich.de:134078
|p openaire
|p open_access
|p driver
|p VDB
|p dnbdelivery
910 1 _ |a Forschungszentrum Jülich GmbH
|0 I:(DE-588b)5008462-8
|k FZJ
|b 0
|6 P:(DE-Juel1)131840
913 2 _ |a DE-HGF
|b Key Technologies
|l Decoding the Human Brain
|1 G:(DE-HGF)POF3-570
|0 G:(DE-HGF)POF3-573
|2 G:(DE-HGF)POF3-500
|v Neuroimaging
|x 0
913 1 _ |a DE-HGF
|b Gesundheit
|l Funktion und Dysfunktion des Nervensystems
|1 G:(DE-HGF)POF2-330
|0 G:(DE-HGF)POF2-333
|2 G:(DE-HGF)POF2-300
|v Pathophysiological Mechanisms of Neurological and Psychiatric Diseases
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF2
913 1 _ |a DE-HGF
|0 G:(DE-HGF)POF2-89573
|v Neuroimaging
|x 1
|4 G:(DE-HGF)POF
|1 G:(DE-HGF)POF3-890
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-800
|b Programmungebundene Forschung
|l ohne Programm
914 1 _ |y 2012
915 _ _ |a Creative Commons Attribution-NonCommercial-NoDerivs CC BY-NC-ND 3.0
|0 LIC:(DE-HGF)CCBYNCND3
|2 HGFVOC
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1040
|2 StatID
|b Zoological Record
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a JCR/ISI refereed
|0 StatID:(DE-HGF)0010
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
920 1 _ |0 I:(DE-Juel1)INM-5-20090406
|k INM-5
|l Nuklearchemie
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-Juel1)INM-5-20090406
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21